Cover Image

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma

Kidney renal papillary cell carcinoma (KIRP) has a high mortality rate and a poor prognosis. Cu concentrations differed significantly between renal cancer tissues and adjacent normal tissues. Cuproptosis is a newly identified cell death. Long non-coding RNAs (lncRNAs) play a crucial role in the prog...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tongjin Xie (Author), Bin Liu (Author), Dongbo Liu (Author), Yusong Zhou (Author), Qingping Yang (Author), Dai Wang (Author), Mengjie Tang (Author), Wei Liu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
by: Lin Pang, et al.
Published: (2023)

Cuproptosis-Related lncRNA Predict Prognosis and Immune Response of LUAD
by: Zhou Q, et al.
Published: (2024)

Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
by: Zheng Zhou, et al.
Published: (2022)

Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer
by: Chun Li, et al.
Published: (2023)

Identification of Hub lncRNAs Along With lncRNA-miRNA-mRNA Network for Effective Diagnosis and Prognosis of Papillary Thyroid Cancer
by: Haiyan Li, et al.
Published: (2021)

LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
by: Rui Huang, et al.
Published: (2020)

An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma
by: Zhenyu Gong, et al.
Published: (2020)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
by: Mengzhe Zhang, et al.
Published: (2023)

Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer
by: Li Liu, et al.
Published: (2023)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
by: Zhenyu Zhang, et al.
Published: (2022)

An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction
by: Zhou Y, et al.
Published: (2024)

A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs
by: Bo Song, et al.
Published: (2022)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
by: Chao Ma, et al.
Published: (2023)

A novel signature of cuproptosis-related lncRNAs predicts prognosis in glioma: Evidence from bioinformatic analysis and experiments
by: Di Chen, et al.
Published: (2023)

Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
by: Liping Wang, et al.
Published: (2022)

Construction of an immunogenic cell death-related LncRNA signature to predict the prognosis of patients with lung adenocarcinoma
by: Shuaishuai Wang, et al.
Published: (2024)

Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
by: Zixuan Zhong, et al.
Published: (2022)

A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
by: Zilu Meng, et al.
Published: (2022)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
by: Ying Zeng, et al.
Published: (2019)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
by: Binliang Gan, et al.
Published: (2023)

Associations of lncRNA H19 Polymorphisms at MicroRNA Binding Sites with Glioma Susceptibility and Prognosis
by: Yujiao Deng, et al.
Published: (2020)

Characterization of m6A-related lncRNA signature in neuroblastoma
by: Liming Li, et al.
Published: (2022)

Prognostic significance of a 4-lncRNA glycolysis-related signature in oral squamous cell carcinoma
by: Liangyin Wu, et al.
Published: (2022)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
by: Yunbao Pan, et al.
Published: (2019)

lncRNA Signature for Predicting Cerebral Vasospasm in Patients with SAH: Implications for Precision Neurosurgery
by: Chen-Yu Pan, et al.
Published: (2020)

Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer
by: Yaobin Lin, et al.
Published: (2022)

Analysis of Immune and Prognostic-Related lncRNA PRKCQ-AS1 for Predicting Prognosis and Regulating Effect in Sepsis
by: Ding X, et al.
Published: (2024)

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma
by: Chi Liu, et al.
Published: (2022)

Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
by: Weifeng Hong, et al.
Published: (2020)

A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer
by: Qi-Tong Xu, et al.
Published: (2023)

A chemoresistance lncRNA signature for recurrence risk stratification of colon cancer patients with chemotherapy
by: Hao Wang, et al.
Published: (2022)

SKF-LDA: Similarity Kernel Fusion for Predicting lncRNA-Disease Association
by: Guobo Xie, et al.
Published: (2019)

Integrated analysis of lncRNA-miRNA-mRNA ceRNA network and the potential prognosis indicators in sarcomas
by: Lu Gao, et al.
Published: (2021)

Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma
by: Ping S, et al.
Published: (2021)

Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma
by: Fengjiao He, et al.
Published: (2023)

Co-regulated ceRNA network mediated by circRNA and lncRNA in patients with gouty arthritis
by: Yanqiu Xu, et al.
Published: (2024)

Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer
by: Xiwen Wu, et al.
Published: (2023)

Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer
by: Songwei Feng, et al.
Published: (2022)

Molecular Characterization and Biological Function of a Novel LncRNA CRNG in Swine
by: Qirong Lu, et al.
Published: (2019)